A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 (LIfT)
This study has been completed.
Sponsor:
Liquidia Technologies, Inc.
Collaborators:
Accelovance Inc.
Children's Hospital Medical Center, Cincinnati
Information provided by (Responsible Party):
Liquidia Technologies, Inc.
ClinicalTrials.gov Identifier:
NCT01224262
First received: October 14, 2010
Last updated: February 25, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2011 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | January 22, 2013 |